-
UK set for cautious budget as borrowing costs climb
-
Afghans compete for jobs, homes as millions return
-
Anthropic's record IPO faces some big questions
-
'They don't care about us': Trump food aid cuts leave Americans struggling and angry
-
US Fed expected to hold rates steady ahead of key midterm elections
-
Meta, Snap head to trial in another case about social media's harms
-
Can this Latin Grammy-winner help Democrats win back Congress?
-
French Senate passes bill to make protesters pay for unrest damage
-
Tuvalu has 'limited' power to halt its fossil fuel investments: NZ govt papers seen by AFP
-
India evacuates tens of thousands as Cyclone Arnab makes landfall
-
Palestinian activist Khalil returns to Columbia after US detention
-
In tight Israel vote, both camps hold out cautious hope
-
Trump drastically loosens oil and gas methane rules
-
AI chip giant SK hynix says quarterly operating profit soars 630%
-
French Senate weighs bill to make protesters pay for unrest damage
-
Youths testify about 'despair' in unprecedented Canadian climate trial
-
'A very sad day': Arteta despair as Arsenal stunned by Fleetwood
-
Syria, Jordan agree to mend ties after deadly strike
-
Charles tackles thorny legacy of slavery on Caribbean trip
-
Arsenal stunned by fourth-tier Fleetwood in League Cup
-
Former Grand Slam winner Wawrinka ends tennis career
-
Last-gasp Sabitzer strike sends Dortmund past Bremen in German Cup
-
Brazil's Flavio Bolsonaro flees to US after election loss
-
Rights groups reject Emirati diplomat for UN top job
-
'Faerie' nights: 'ACOTAR' fans finally get their book
-
Flavio Bolsonaro headed to US after Brazil election defeat: US media
-
American woman convicted of getting military training from Islamic State
-
Alcaraz and Zverev win Vienna openers
-
Israel opposition holds narrow edge over Netanyahu in first projections
-
Tech firms gain ahead of Fed decision, results from AI giants
-
Floriani hits maiden goal as Lazio go top
-
Syria condemns deadly Jordan strikes as 'unacceptable violation'
-
Trump set to drastically loosen oil and gas sector's methane rules
-
England's Fin Smith in race against time to face Australia
-
Storied Paris department store seeks bankruptcy protection
-
UN nuclear watchdog chief urges Iran to grant access
-
Xhaka, Embolo can return to Swiss squad after fake Covid docs affair
-
Boeing shares tumble after it releases cautious growth forecast
-
Allegri suspended for two Serie A games after red card
-
Lula's re-election revives Brazil-US tensions
-
Flight data, satellite images reveal growing US role at Ecuador base
-
Carney moves to remake Canada alliances as US ties strained
-
McInnes feels 'guilt' ahead of Hearts return with Rangers
-
Serbia's students demand state media chiefs resign after poll win
-
Brazil's Lula turns 81, vows to work '24 hours a day'
-
Starc takes six as Australia fight back in South Africa decider
-
Boeing releases cautious growth plan as shares fall sharply
-
UK man offered drugged wife to strangers online for sex: court
-
Exiled Russian dissident Navalnaya warns dictators becoming 'more cunning'
-
Africa Ebola outbreak passes 10,000 cases, mostly in DR Congo
Can dogs sniff cancer? AI joins the hunt in India
When rescue dog Chloe is not tumbling across the grass on a farm outside India's tech capital Bengaluru, she is learning to sniff human breath for cancer with a little help from AI.
Fitted with a 3D-printed helmet and harness packed with sensors, Chloe is part of experimental efforts to use dogs' extraordinary sense of smell to develop a non-invasive test for the disease.
A growing body of global research suggests dogs can be trained to detect cancer and other human illnesses, from Parkinson's to Covid-19.
The Bengaluru-based startup Dognosis is using AI to analyse dogs' brain activity, respiration and body language -- turning their reaction to scent into data.
"In an hour, they can do thousands of sniffs," co-founder Akash Kulgod, 26, told AFP. "Each sniff can evaluate a sample."
Dognosis hopes to launch commercially next year, which it says would make it the third company of its kind, after firms from Germany and Israel.
Early detection can make a crucial difference to cancer survival rates, but in India many patients are diagnosed only after the disease has advanced.
Dog sniffs could provide an easy and affordable first layer of screening to be deployed at scale, finding potential cases for further testing.
As it chases commercial approval, Dognosis -- backed by venture-capital firms including Accel India -- is collaborating with government medical institutions for its research.
Chloe, a Labrador mix, is one of 15 dogs being coached by the startup, clad in customised data-gathering helmets.
"It's like a doggy 'Iron Man' suit," said Kulgod, who comes from a family of doctors and studied cognitive science at the University of California, Berkeley.
- 'Promising' study -
Research suggests diseases can alter the chemicals released by the body, creating distinctive odours.
Dogs have around 300 million scent receptors, compared to about five million in humans.
The testing method is simple: a patient breathes into a cotton mask for about 10 minutes, and the mask is then sealed in a bag and taken to the lab. Patients do not meet the dogs.
A recent Dognosis study of more than 1,500 participants, involving six hospitals in Karnataka state, was published in the Journal of Clinical Oncology.
The company said it achieved an accuracy rate of more than 90 percent across seven major types of cancer, and now plans to test in real-world programmes.
Cancer specialists in Bengaluru independent of the project voiced cautious optimism.
"The study is promising, as an early signal," said Santhosh Kumar Devadas, head of oncology at Ramaiah Memorial Hospital.
"But they need to do the study with a much larger group before we make any definitive conclusions."
Neelesh Reddy, a senior consultant oncologist at Manipal Hospitals, told AFP that "only time will tell how this technology will be useful to the actual patients".
- Dog 'work-life balance' -
India has described cancer as a major public health concern, saying one in nine of its 1.4 billion people are likely to develop the disease.
Dognosis says it aims to improve "proactive and preventative medicine" while boosting "human-canine communication".
Most of the dogs are beagles, along with some Malinois and Shepherd mixes, brought on board through adoption or legal breeders.
But only the best are selected, said Kulgod. The dog team individually lists each animal on the company website as an official "sniffer", alongside their photographs.
All have a great "work-life balance", with work time limited to around 30-45 minutes a day, he added.
At a centre called "Sniffspace", dogs test human samples on platforms equipped with automatic feeders dispensing dog treats.
Kulgod's co-founder Itamar Bitan, 28, who spent four years in an Israeli special-forces canine unit, said the dogs were trained using "positive reinforcement" to detect a "specific funky smell" for a reward.
"Some of the dogs run directly to the feeder expecting rewards, some dogs freeze, some dogs will scratch the sample with excitement," Bitan said.
"But, as long as the machine that learns how the dogs react to the sample is very consistent... we don't really mind."
T.Germann--VB